Related Experiment Video
Updated: Jul 9, 2026

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
Published on: March 25, 2014
The antibacterial activity of peptides derived from human beta-2 glycoprotein I is inhibited by protein H and M1
Maria Nilsson1, Sylwia Wasylik, Matthias Mörgelin
1Division of Infection Medicine, Department of Clinical Sciences, Lund University, Lund, Sweden. maria_e.nilsson@hotmail.com
Abstract:
During the last years, the importance of antibacterial peptides has attracted considerable attention. We report here that peptides derived from the fifth domain of beta-2 glycoprotein I (beta(2)GPI), a human heparin binding plasma protein, have antibacterial activities against Gram-positive and Gram-negative bacteria. Streptococcus pyogenes, an important human pathogen that can survive and grow in human blood, has developed mechanisms to escape the attack by these peptides. Thus, protein H and M1 protein, two surface proteins of the highly pathogenic S. pyogenes AP1 strain, bind full-length beta(2)GPI and thereby prevent the processing of beta(2)GPI by proteases from polymorphonuclear neutrophils (PMNs) into antibacterial peptides. In addition, protein H and M1 protein, released from the bacterial cell wall by PMN-derived proteases, bind to, and inhibit the activity of, beta(2)GPI-derived antibacterial peptides. Taken together, the data suggest that the interaction between the streptococcal proteins and beta(2)GPI or beta(2)GPI-derived peptides presents a novel mechanism to resist an antibacterial attack by beta(2)GPI-cleavage products.
Insights
Antibacterial peptides from beta-2 glycoprotein I fight bacteria. However, Streptococcus pyogenes uses surface proteins H and M1 to block these peptides, evading the immune response.
Area of Science:
- Biochemistry
- Immunology
- Microbiology
Background:
- Antibacterial peptides are crucial for innate immunity.
- Beta-2 glycoprotein I (beta(2)GPI) is a human plasma protein with potential antibacterial properties.
- Streptococcus pyogenes is a significant human pathogen that employs sophisticated evasion strategies.
Purpose of the Study:
- To investigate the antibacterial activity of beta(2)GPI-derived peptides.
- To elucidate the mechanisms by which Streptococcus pyogenes evades attacks by these peptides.
Main Methods:
- Analysis of antibacterial activity of beta(2)GPI peptides against Gram-positive and Gram-negative bacteria.
- Investigation of the interaction between S. pyogenes surface proteins (H and M1) and beta(2)GPI.
- Assessment of the role of S. pyogenes proteins in inhibiting beta(2)GPI processing and peptide activity.
Main Results:
- Peptides derived from beta(2)GPI exhibit antibacterial activity.
- Streptococcus pyogenes proteins H and M1 bind to beta(2)GPI, preventing its cleavage into antibacterial peptides by neutrophil proteases.
- These streptococcal proteins also bind and inhibit the activity of beta(2)GPI-derived antibacterial peptides.
Conclusions:
- Streptococcal proteins H and M1 provide a novel resistance mechanism against beta(2)GPI-derived antibacterial peptides.
- This interaction highlights a sophisticated immune evasion strategy employed by S. pyogenes.
- Understanding this interaction could lead to new therapeutic approaches against bacterial infections.
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Inhibitors of Bacterial Protein Synthesis
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Determinants of Bacterial Pathogenicity and Virulence

